WINSTON-SALEM, N.C. – May 31, 2011 – The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake ...

LONDON, Nov. 14, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced the continued commercial expansion of its HbA1c test, for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Using HbA1c testing to screen adults from a large U.K.

A new saliva test and earlier use of the HbA 1c blood test could pick up type 2 diabetes in high-risk patients earlier than methods in current use, show data from 2 studies. Both tests could both ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure The Quo-Test ® is a fully automated ...

ABBOTT PARK, Ill., June 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 ...

Please provide your email address to receive an email when new articles are posted on . Most primary care providers who were surveyed said they use an HbA1C test to screen patients with polycystic ...

Lumiradx Ltd. has secured CE marking for its HbA1c test for diabetes. The point-of-care (POC), automated fingerstick assay is run on the Lumiradx portable platform and designed to provide connected ...

EKF Diagnostics, the global in vitro diagnostics company, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V. for the distribution of its Quo-Test ® HbA1c ...

Diabetic patients receive standard-of-care treatment when they receive their diagnosis. This includes visiting their primary care doctors and learning about the disease and why and how they need to ...

A simple blood test that does not require overnight fasting has been found to be an accurate screening tool for identifying youth at risk for type 2 diabetes and heart disease risk later in life. A ...